Spironolactone 50 mg Tablet (Spirowise-50)
Spironolactone 50 mg
| Composition | Spironolactone 50 mg |
|---|---|
| Dosage Form | Tablet |
| Pack Type | Box |
| Pack Size | 10 x 10 (Blister) |
| MRP | ₹ 489 |
| Therapy | Cardiac + Diabetic — Aldosterone receptor antagonist (potassium-sparing diuretic) |
| Storage | Store below 25°C. |
WhatsApp EnquiryCall: +919041677932
For chemists, distributors and doctors: Spirowise-50 (spironolactone 50 mg tablet) is available from Trumac Healthcare on a PCD franchise with monopoly rights for your district, and as wholesale stock for licensed distributors. No franchise fee; first order from ₹25,000 – work out your margin with the PTR / PTS calculator.
Buying this composition for PCD franchise, wholesale or under your own brand? See Spironolactone 50 mg Tablet – manufacturer, supplier & PCD franchise for available packs and brand options.
See the full cardiac tablets range – manufacturer, supplier and PCD franchise: telmisartan, olmesartan, amlodipine, metoprolol, rosuvastatin, atorvastatin, clopidogrel, ticagrelor, trimetazidine and their combinations.
About Spirowise-50 Tablet
Spirowise-50 Tablet contains Spironolactone 50 mg. Spironolactone is a competitive aldosterone receptor antagonist with potassium-sparing diuretic action and additional anti-androgen effect at higher doses.
Indicated for chronic heart failure (RALES trial — mortality benefit), resistant hypertension (PATHWAY-2 trial), primary hyperaldosteronism, cirrhotic ascites and female acne / hirsutism (off-label).
Camrut Healthcare manufactures the Spirowise range under WHO-GMP conditions for PCD pharma franchise across India.
Spirowise-50 का उपयोग (हिंदी में): हृदय और सूजन की दवा। सभी Trumac दवाओं के उपयोग हिंदी और अंग्रेज़ी में – Trumac Healthcare tablet uses A–Z। दवा हमेशा डॉक्टर की सलाह से ही लें।
Indications
- Heart failure (NYHA III-IV, on standard therapy)
- Resistant hypertension
- Primary hyperaldosteronism (Conn's)
- Cirrhotic ascites
- Female adult acne and hirsutism (off-label)
Mechanism of Action
Spironolactone competitively binds the mineralocorticoid receptor in the distal renal tubule, blocking aldosterone-mediated Na+ retention and K+ excretion. Modest diuretic effect with potassium retention. At higher doses, it also antagonises androgen receptors and inhibits testosterone synthesis.
Dosage & Administration
- HF: 25–50 mg once daily
- Hypertension: 25–100 mg/day
- Take with food
- Monitor potassium and renal function
Side Effects
- Hyperkalaemia
- Gynaecomastia (in men, dose-related)
- Menstrual irregularities (in women)
- Hyponatraemia
- Renal impairment
Contraindications & Precautions
- Hyperkalaemia
- Severe renal impairment
- Anuria
- Addison’s disease
- Concurrent eplerenone or potassium supplements
Storage
Store below 25°C.
From Trumac Healthcare, a pharma franchise company in India, available on a monopoly basis – see the cardiac-diabetic products franchise product list (PDF). See our full PCD franchise tablets range. Comparing companies? See the compare cardiac diabetic PCD companies. No franchise fee; minimum first order ₹25,000 – cost and documents.
Spirowise-50 Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Frequently Asked Questions
q
a
q
a
q
a
q
a
q
a
Related Products
